NEW YORK (GenomeWeb News) – BG Medicine today announced a deal with Kindstar Diagnostics to offer galectin-3 testing services in China.

Kindstar, based in Wuhan, China, is the largest esoteric diagnostic testing business in the country, BGM said, and offers laboratory testing services to more than 2,000 hospitals there. BGM noted that much of China's population pays out of pocket for essential medical services, providing "a ready market for diagnostic testing services like galectin-3 testing," by allowing BGM to bypass reimbursement issues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.